Ubiquitous transcription factors NF1 and Spl are involved in the androgen activation of the mouse vas deferens protein promoter

Molecular and Cellular Endocrinology

Volumn 132, Issue 1-2, 1997, Pages 13-23

  Darne, C H ^a   Morel, L ^a   Claessens, F ^b   Manin, M ^a   Fabre, S ^a   Veyssiere G ^a   Rombauts, W ^b   Jean, C L ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Androgen response element; Mouse vas deferens protein; Mutagenesis; NF1; Spl; Transcription factor; Transcriptional regulation; Transient transfection

Indexed keywords

ALDEHYDE REDUCTASE; ANDROGEN; ANDROGEN RECEPTOR; CELL EXTRACT; NUCLEAR FACTOR I; RECOMBINANT PROTEIN; SECRETORY PROTEIN; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA FOOTPRINTING; DNA SEQUENCE; ELECTROPHORETIC MOBILITY; EPITHELIUM CELL; GENE; GENE ACTIVATION; GENETIC TRANSFECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; VAS DEFERENS;

ALDEHYDE REDUCTASE; ANDROGENS; ANIMALS; BASE SEQUENCE; CELL LINE; DNA-BINDING PROTEINS; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; NFI TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0030930710     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00116-0     Document Type: Article

References (12)

1. Adler. A.J., Danielsen, M., Robins, D.M., 1992. Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with non receptor factors. Proc. Natl. Acad. Sci. USA 89, 11660-11663.
2. Archer, T.K., Cordmgley, M.G., Wolford, R.G., Hager, G.L., 1991. Transcription factor access is mediated by accurately positionned nucleosomes on the mouse mammary tumor virus promoter. Mol. Cell. Biol. 11. 688-698.
3. Bakker, O., Philipsen, J.N.J., Hennis, B.C., Ab, G., 1988. Estrogeninducible binding of a nuclear factor to the vitellogenin upstream region. Mol. Cell. Biol. 8, 4557-4560.
4. Brinkmann, A.O., Faber, P.W., Van Rooij, H.C.J., Kuiper, G.G.M., Ris. C., Klaassen, P., Van Der Korput, J.A.G.M., Voorhorst. M.M., Van Laar, J.H., Mulder. E., Trapman, J., 1989. The human androgen receptor: domain structure, genomic organization and regulation of expression. J. Steroid Biochem. 34, 307310.
5. Bruggemeier. U., Kalff. M., Franke, S., Scheidereit, C., Beato, M., 1991. Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistk: interaction with hormone receptors. Cell 64, 565-572.
6. Brüggemeir, U., Rogge, L., Winnacker, E.L., Beato, M., 1990. Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J. 9, 2233-2239.
7. Buetti, E., Kühnel, B., Diggelmann. H., 1989. Dual function of a nuclear factor I binding site in MMTV transcription regulation. Nucleic Acids Res. 17, 3065-3078.
8. Cardinaux. J.R., Chapel. S., Wahli. W., 1994. Complex organization of CTF/NF1, C/EBP and HNF3 binding sites within the promoter of the liver-specific vitellogenin gene. J. Biol. Chem. 269, 32947-32956.
9. Carson-Jurica, M., Schrader, W.T., O'Malley, B W., 1990. Steroid receptor superfamily: structure and functions. Endocr. Rev. 11, 201-220.
10. Cato, A.C.B., Micsicek, R., Schutz, G., Arnemann, J., Beato, M., 1986. The hormone regulatory element of mouse mammary tumor virus mediates progesterone induction. EMBO J. 5, 2237-2240.
11. Cells, L., Claessens, F., Peelers, B., Heyns, W., Verhoeven, G., Rombauts. W., 1993. Proteins interacting with an androgen-responsive unit in the C3(1) gene intron. Mol. Cell. Endocrinol. 94, 165-172.
12. Chen, J.L., Attardi, D.A., Verrijzer, C.P., Yokomori, K., Tijan, R., 1994. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79, 79-93.